Results 331 to 340 of about 976,952 (369)
Some of the next articles are maybe not open access.
Efficacy of reporting systems of adverse reactions to drugs and care.
Scandinavian journal of social medicine, 1983Only 13% of adverse drug reactions that should have been reported to the Committee on Side Effects in Sweden according to the criteria published by the National Board of Health and Welfare, were actually reported by the responsible doctors. This was found in a prospective study of all adverse reactions established in 1 271 patients at a department of ...
Britton S, Jorup-Rönström C
openaire +3 more sources
System for voluntary reporting of adverse drug reactions in a university hospital
American Journal of Health-System Pharmacy, 1989The development and implementation of a system to improve voluntary reporting of adverse drug reactions (ADRs) is described. A preliminary study comparing three concurrent voluntary reporting systems at a 327-bed university teaching hospital demonstrated the ability of medical records personnel to identify ADRs that were documented in the medical ...
Lynda Barstow +2 more
openaire +3 more sources
Developing an Adverse Drug Reaction Reporting System at a Teaching Hospital
Basic & Clinical Pharmacology & Toxicology, 2008Abstract: Adverse drug reactions (ADRs) are a frequent cause for hospitalization and occur often in hospitalized patients. The objective of this study was to establish an ADR reporting and monitoring system at a teaching hospital. The pharmacovigilance unit of Masih Daneshvari hospital was established by a clinical pharmacist and a clinical ...
Fanak Fahimi +2 more
openaire +3 more sources
Patient satisfaction with a hospital adverse drug reaction reporting system
Journal of Pharmacy Practice and Research, 2020AbstractAimTo evaluate patients' satisfaction with the adverse drug reactions (ADR) warning card model used within a metropolitan hospital network in Melbourne, Australia.Methods and ResultsA cross‐sectional survey, with interviewer‐administered questionnaire, of patients who experienced an ADR was conducted.
Matthew W. Scott +4 more
openaire +2 more sources
Respiratory Care, 2021
Between 2012 and 2017, 25 new medications or combination products were approved by the Food and Drug Administration (FDA) for use in treatment of chronic lower respiratory diseases (CLRDs). With limited data on post-marketing patient exposure to these drugs, their safety profiles remain unknown. This study aims to provide post-marketing surveillance of
Sandra L. Kane-Gill +5 more
openaire +3 more sources
Between 2012 and 2017, 25 new medications or combination products were approved by the Food and Drug Administration (FDA) for use in treatment of chronic lower respiratory diseases (CLRDs). With limited data on post-marketing patient exposure to these drugs, their safety profiles remain unknown. This study aims to provide post-marketing surveillance of
Sandra L. Kane-Gill +5 more
openaire +3 more sources
Identifying adverse reactions to drugs reporting systems
Clinics in Dermatology, 1986Abstract The dermatologist's concern about adverse reactions to drugs can be viewed from two perspectives. Most often, dermatologists are confronted with skin reactions to drugs used in the treatment of a wide variety of noncutaneous diseases. Less frequently, but sometimes more dramatically, dermatologists care for a patient who may have developed a ...
openaire +3 more sources
Under-reporting of adverse drug reactions
European Journal of Clinical Pharmacology, 1998Spontaneous reporting is the most common method used in pharmacovigilance and the best one to generate signals on new or rare adverse drug reactions (ADRs). Under-reporting is a major drawback of this system. The objective of this study was to quantify the extent of under-reporting in general practice and to assess the factors which influence it ...
Y. Moride +5 more
openaire +2 more sources
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System
Expert Opinion on Drug Safety, 2018Possible relationship between drug exposure and multiple sclerosis (MS) development is insufficiently investigated, and further challenged by the incomplete understanding of MS etiopathogenesis. The study aims to investigate whether drug exposure could contribute to MS, by analyzing worldwide spontaneous reporting archives of adverse drug reaction ...
Antonazzo, Ippazio Cosimo +7 more
openaire +5 more sources
Annals of Pharmacotherapy, 2008
Background: Adverse drug reaction (ADR) spontaneous reporting is the primary method of postmarketing drug surveillance: although it is an important part of postmarketing drug surveillance, it is underused. Before 2004, almost no ADRs were reported in our 400-bed hospital.
Aránzazu Aguinagalde +5 more
openaire +3 more sources
Background: Adverse drug reaction (ADR) spontaneous reporting is the primary method of postmarketing drug surveillance: although it is an important part of postmarketing drug surveillance, it is underused. Before 2004, almost no ADRs were reported in our 400-bed hospital.
Aránzazu Aguinagalde +5 more
openaire +3 more sources
Discovery of New Adverse Drug Reactions
JAMA, 1984Recently, several studies of spontaneous reporting systems (SRSs) have reported on the published literature's role in producing first reports of new adverse drug reactions. In order to provide further information on other components of SRS, the Food and Drug Administration's SRS was examined with regard to its effectiveness and efficiency in ...
Deanne E. Knapp, Allen C. Rossi
openaire +3 more sources